Skip to content
  1. Home/
  2. Latest news/
  3. Health & wellness/
  4. Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Freedom of breath, fountain of life: How a first-of-its-kind partnership has saved thousands of babies in China

Helping Babies Breathe

A quadruplet baby from the Shen family who needed neonatal resuscitation at birth

Childbirth should be a moment to celebrate the miracle of life, but as many as 1 in 10 newborns are unable to breathe upon entering the world.

The condition, known as birth asphyxia, is among the world’s leading causes of infant death. And a decade ago, it accounted for 20% of China’s infant mortality rate—that’s a shocking 73,000 babies lost each year.

But a simple, low-tech medical technique called neonatal resuscitation can help prevent it. That’s why Johnson & Johnson partnered with the Chinese Ministry of Health and other organizations in an effort to ensure that caregivers in every Chinese hospital received the training they needed to administer the procedure.

Ten years later, we’re proud to say that this unique public/private partnership, known as “Freedom of Breath, Fountain of Life,” has helped over 100,000 Chinese babies take their first breath. And after a decade of success, we’re committed to keeping the partnership going for another five years.

But don’t just take our word for it: Watch the moving video below and meet six kids who are alive and thriving, thanks to the historic partnership that empowered everyone from midwives to doctors to save precious lives.

hqdefault.jpg
Celebrating Life, One Breath at a Time

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.